K. Raja Reddy

Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases

Scott J. Hecker, K. Raja Reddy, Olga Lomovskaya et al. · Journal of Medicinal Chemistry · 2020 · 212 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes

Mark D. Erion, Paul D. van Poelje, Qun Dang et al. · Proceedings of the National Academy of Sciences · 2005 · 162 citations

Life Sciences, Biochemistry, Pharmacology +17

Design, Synthesis, and Characterization of a Series of Cytochrome P₄₅₀3A-Activated Prodrugs (HepDirect Prodrugs) Useful for Targeting Phosph(on)ate-Based Drugs to the Liver^§

Mark D. Erion, K. Raja Reddy, Serge H. Boyer et al. · Journal of the American Chemical Society · 2004 · 160 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Total synthesis of hemibrevetoxin B and (7a.alpha.)-epi-hemibrevetoxin B

K. C. Nicolaou, K. Raja Reddy, G. SKOKOTAS et al. · Journal of the American Chemical Society · 1993 · 116 citations

Natural Sciences, Chemistry, Pharmacology +7

Discovery of Potent and Specific Fructose-1,6-Bisphosphatase Inhibitors and a Series of Orally-Bioavailable Phosphoramidase-Sensitive Prodrugs for the Treatment of Type 2 Diabetes

Qun Dang, Srinivas Rao Kasibhatla, K. Raja Reddy et al. · Journal of the American Chemical Society · 2007 · 97 citations

Life Sciences, Medicinal Chemistry, Pharmacology +17